動物幹細胞治療市場- 世界の産業規模、シェア、動向、機会、予測、2018年-2028年、タイプ別、用途別、地域別

動物幹細胞治療の世界市場は、2022年に2億1,025万米ドルと評価され、2028年までのCAGRは6.06%で、予測期間中に目覚ましい成長を予測されています。

動物幹細胞治療の世界市場とは、動物の様々な病状を治療するための幹細胞ベースの治療法の応用に関わる産業を指します。この市場は、ペットや家畜、さらには野生動物を含む動物の健康と福祉を向上させる可能性があることから、大きな注目を集めています。

ペットの健康と福祉に対する意識は新たな高みに達しています。ペットの飼い主は、毛むくじゃらの仲間の特定のニーズや健康状態について、これまで以上に情報を得るようになっています。このような意識の高まりは、インターネット、ソーシャルメディア、獣医師や動物愛護団体による教育キャンペーンを通じて、容易に入手できる情報から生じています。

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 動物幹細胞治療の世界市場展望

• 市場規模と予測
  • 金額別
• 市場シェアと予測
  • タイプ別（イヌ幹細胞治療、ウマ幹細胞治療）
  • 用途別（動物病院、調査機関）
  • 地域別
  • 企業別（2022年）
• 製品市場マップ
  • タイプ別
  • 用途別
  • 地域別

第6章 北米の動物幹細胞治療市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • タイプ別
  • 用途別
  • 国別
• 北米国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の動物幹細胞治療市場展望

• 市場規模と予測
  • 金額別
• 市場シェアと予測
  • タイプ別
  • 用途別
  • 国別
• 欧州国別分析
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン

第8章 アジア太平洋の動物幹細胞治療市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • タイプ別
  • 用途別
  • 国別
• アジア太平洋地域国別分析
  • 中国
  • 日本
  • インド
  • オーストラリア
  • 韓国

第9章 南米の動物幹細胞治療市場展望

• 市場規模および予測
  • 金額別
• 市場シェアと予測
  • タイプ別
  • 用途別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの動物幹細胞治療市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • タイプ別
  • 用途別
  • 国別
• MEA：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向市場動向と発展

• 最近の展開
• 合併・買収
• 製品発表

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Business Overview
• Product Offerings
• Recent Developments
• Financials（As Reported）
• Key Personnel
• SWOT Analysis
  • Ardent Animal Health
  • Vet Stem Inc
  • Medrego
  • Vetbiologics
  • VETHERAPY
  • Celavie Biosciences
  • Magellan Stem Cells
  • Animal General
  • Animal Cell Therapies, Inc.
  • Cell Therapy Sciences Ltd

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Animal Stem Cell Therapy Market has valued at USD 210.25 million in 2022 and is anticipated to project impressive growth in the forecast period with a CAGR of 6.06% through 2028. The Global Animal Stem Cell Therapy Market refers to the industry involved in the application of stem cell-based therapies to treat various medical conditions in animals. This market has gained significant attention due to its potential in improving the health and well-being of animals, including pets, livestock, and even wildlife.

Key Market Drivers

Rising Awareness and Demand for Advanced Veterinary Care

The awareness of pet health and well-being has reached new heights. Pet owners are more informed than ever about the specific needs and health conditions of their furry companions. This heightened awareness stems from readily available information through the internet, social media, and educational campaigns by veterinarians and animal welfare organizations.

Pets are no longer mere animals; they have evolved into cherished members of the family. The humanization of pets has led to a transformation in pet care. Many pet owners are willing to go to great lengths to provide their pets with the best possible healthcare, mirroring the kind of care they would seek for themselves.

As the bond between humans and animals strengthens, so does the investment in pet healthcare. Pet owners are now more willing to spend on diagnostic tests, surgeries, medications, and therapies to ensure the health and happiness of their pets. This willingness to invest financially in pet healthcare extends to advanced treatments like stem cell therapy.

Stem cell therapy has gained recognition as a highly effective and minimally invasive treatment option for various animal health issues. Whether it's addressing joint problems, neurological conditions, or other ailments, pet owners and veterinarians alike are acknowledging the therapeutic potential of stem cells.

The proliferation of success stories and positive testimonials from pet owners who have witnessed the benefits of stem cell therapy in their pets has played a pivotal role in driving awareness. Personal accounts of pets experiencing improved mobility, pain relief, and a better quality of life after undergoing stem cell treatment serve as compelling evidence of its efficacy.

With the growing demand for advanced veterinary care, more veterinary clinics and hospitals are incorporating stem cell therapy into their service offerings. This increased accessibility makes it easier for pet owners to consider stem cell therapy as a viable option for their pets' health issues.

Veterinarians are actively promoting the benefits of stem cell therapy. They are conducting seminars, workshops, and informational sessions to educate pet owners about the potential of this treatment modality. Their advocacy has contributed significantly to the rising awareness and demand for advanced veterinary care.

Expanding Pet Ownership and Humanization of Pets

The first and most evident factor contributing to the expansion of the animal stem cell therapy market is the unprecedented surge in pet ownership. Across the globe, more people are welcoming furry, feathered, or scaly companions into their homes. This growing pet population encompasses a wide variety of animals, from dogs and cats to birds, reptiles, and small mammals.

The demographic landscape is also undergoing change, with an increasing number of single-person households and smaller families. In such settings, pets often play the role of cherished family members and can receive even more attention and care.

Pets are no longer just animals living alongside their human owners; they are integral members of the family. The phenomenon of "humanization of pets" means that pets receive similar levels of attention, care, and emotional investment as human family members. This shift in perspective has profound implications for their healthcare.

As pets become more deeply integrated into people's lives, pet owners have raised their expectations regarding the standard of care their animals receive. This includes not only routine veterinary visits but also advanced treatments and therapies that can enhance their pets' quality of life.

Pet owners are increasingly willing to invest in the health and well-being of their furry friends. They recognize that preventive care, regular check-ups, and advanced treatments like stem cell therapy can extend the lifespan and improve the overall health of their pets.

The growing humanization of pets has coincided with increased awareness of innovative treatments such as stem cell therapy. Pet owners are more likely to explore and consider these therapies as viable options when confronted with a pet's medical condition.

Advances in Stem Cell Research and Technology

One of the cornerstones of progress in animal stem cell therapy is the enhanced understanding of stem cell biology. Researchers have made significant strides in deciphering the properties, behavior, and differentiation capabilities of different types of stem cells. This deepened knowledge has paved the way for more precise and effective therapeutic applications.

Advancements in stem cell research have led to the development of refined techniques for isolating stem cells from various sources. Whether sourced from bone marrow, adipose tissue, or other origins, these isolation methods have become more efficient and less invasive. This has made it easier to harvest stem cells for therapy, minimizing discomfort and risk for animals.

The establishment of standardized protocols and quality control measures has been instrumental in ensuring the safety and consistency of animal stem cell therapies. These protocols govern the isolation, expansion, and administration of stem cells, reducing variability and enhancing treatment reliability.

Researchers have identified and explored a broader range of stem cell sources. Beyond traditional sources like bone marrow and adipose tissue, scientists have investigated stem cells derived from umbilical cord blood, dental pulp, and even induced pluripotent stem cells (iPSCs). This diversity of sources allows for greater flexibility in tailoring treatments to specific conditions.

The establishment of stem cell banks for animals has facilitated access to a readily available supply of stem cells for therapeutic purposes. These banks store cryopreserved stem cells, ensuring their viability and availability for future treatments.

In vitro expansion and culturing of stem cells have become more sophisticated and reproducible. This is crucial for generating the large numbers of cells required for effective therapy. These advancements have also enabled the creation of stem cell lines specific to certain animal breeds or species.

Diversification of Applications

Traditionally, stem cell therapy was primarily employed to address musculoskeletal conditions such as osteoarthritis, ligament injuries, and joint problems in animals. However, recent advancements in research have expanded the scope to encompass various medical conditions across different species.

One of the emerging frontiers in animal stem cell therapy is the treatment of cardiac conditions. Stem cells have shown potential in regenerating damaged cardiac tissue, enhancing heart function, and improving the overall quality of life for animals suffering from heart diseases.

Stem cell therapy has exhibited promise in the treatment of neurological disorders in animals, including conditions like spinal cord injuries, degenerative myelopathy, and even epilepsy. These applications offer hope for improved mobility and neurological function in affected animals.

Autoimmune disorders can be challenging to manage in animals. Stem cell therapy has been investigated as a means to modulate the immune system and reduce the severity of autoimmune conditions, providing a novel approach to treatment.

Gastrointestinal issues, such as inflammatory bowel disease, are common in animals. Stem cell therapy may help repair damaged intestinal tissue and alleviate symptoms, offering a non-surgical alternative to treatment.

Stem cells have regenerative properties that make them valuable for promoting wound healing and addressing skin conditions in animals. This application is particularly relevant for conditions like chronic wounds and dermatological disorders.

In cases of injuries or surgeries, stem cell therapy can be used in conjunction with rehabilitation programs to expedite recovery. The regenerative properties of stem cells support tissue repair and can help animals regain mobility and function more quickly.

Key Market Challenges

Safety and Efficacy Concerns

Ensuring the safety and efficacy of stem cell therapies in animals remains a paramount concern. While the therapy holds immense promise, there is a need for extensive research and clinical trials to establish its long-term safety profile and effectiveness for various conditions in different animal species.

Standardization of Protocols

Standardizing protocols for stem cell therapy across the veterinary industry is an ongoing challenge. Lack of uniformity in treatment protocols can lead to variability in outcomes, making it challenging to compare results and establish best practices.

High Treatment Costs

The cost of stem cell therapy can be prohibitively high for some pet owners and agricultural producers. Factors such as the cost of stem cell isolation, culturing, and administration contribute to the overall expense. The affordability of these treatments is a critical consideration for market growth.

Key Market Trends

Personalized Medicine in Veterinary Care

The concept of personalized medicine is gaining ground in veterinary care. Veterinarians are increasingly tailoring stem cell therapies to individual animals based on their unique health profiles, genetics, and specific medical conditions. This personalized approach enhances treatment efficacy and outcomes.

Emerging Regenerative Medicine Technologies

Regenerative medicine technologies are advancing rapidly, offering novel approaches to enhance the effectiveness of stem cell therapies. Techniques like tissue engineering, 3D bioprinting, and gene editing are being integrated with stem cell treatments to create innovative solutions for challenging health issues in animals.

Microbiome and Immunotherapy Integration

The emerging understanding of the gut microbiome's impact on overall health is leading to innovative approaches that combine stem cell therapy with immunotherapy and microbiome modulation. This holistic approach can address various health issues by targeting the immune system and microbiome.

Segmental Insights

Type Insights

Based on the category of Type, Dogs Stem Cell Therapy is poised to dominate the Global Animal Stem Cell Therapy Market in 2022 for several compelling reasons. Firstly, the growing awareness and concern for pet health and longevity has led to an increased demand for innovative treatments, and stem cell therapy offers a promising solution for a wide range of canine ailments. Additionally, dogs, being one of the most popular pets worldwide, represent a substantial market in themselves. The proven efficacy of stem cell therapy in treating various canine conditions, including osteoarthritis and degenerative diseases, further bolsters its potential dominance. Furthermore, advancements in research and development, along with a burgeoning number of veterinary clinics offering these services, are making the treatment more accessible to pet owners. As a result, Dogs Stem Cell Therapy is positioned to lead the way in the global animal stem cell therapy market, addressing the growing need for effective and compassionate care for our four-legged companions.

Application Insights

Veterinary hospitals are poised to dominate the Global Animal Stem Cell Therapy Market in 2022 for several compelling reasons. Firstly, these facilities offer a level of expertise and specialized equipment essential for administering stem cell treatments effectively and safely. This ensures that pet owners have confidence in the quality of care their animals receive. Secondly, veterinary hospitals often serve as hubs for cutting-edge research and development in the field of animal health, allowing them to stay at the forefront of stem cell therapy advancements. Moreover, these hospitals benefit from a broad network of referrals from general practitioners, expanding their reach and client base. As the demand for innovative and compassionate veterinary care continues to rise, veterinary hospitals' expertise and resources position them as key players in driving the growth and dominance of the global animal stem cell therapy market.

Regional Insights

North America is poised to dominate the Global Animal Stem Cell Therapy Market in 2022 for several compelling reasons. Firstly, the region boasts a highly developed and well-regulated veterinary healthcare system, which fosters innovation and ensures the safety and efficacy of stem cell therapies. Secondly, North America's substantial pet ownership rates and a culture of proactive pet healthcare have created a substantial market demand for advanced treatments like stem cell therapy. Additionally, the presence of leading research institutions, pharmaceutical companies, and veterinary hospitals dedicated to animal health in North America accelerates the pace of innovation and the adoption of stem cell therapies. Furthermore, a robust infrastructure for clinical trials and a well-established network of veterinarians makes it easier for pet owners to access these therapies. In summary, North America's combination of strong market demand, research excellence, regulatory framework, and accessibility positions it to dominate the global animal stem cell therapy market.

Key Market Players

Ardent Animal Health

Vet Stem Inc

Medrego

Vetbiologics

VETHERAPY

Celavie Biosciences

Magellan Stem Cells

Animal General

Animal Cell Therapies, Inc.

Cell Therapy Sciences Ltd

Report Scope:

In this report, the Global Animal Stem Cell Therapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Animal Stem Cell Therapy Market, By Type:

• Dogs Stem Cell Therapy
• Horses Stem Cell Therapy

Animal Stem Cell Therapy Market, By Application:

• Veterinary Hospitals
• Research Organizations

Animal Stem Cell Therapy Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• Germany
• United Kingdom
• France
• Italy
• Spain
• Asia-Pacific
• China
• Japan
• India
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait

Competitive Landscape

• Company Profiles: Detailed analysis of the major companies present in the Global Animal Stem Cell Therapy Market.

Available Customizations:

• Global Animal Stem Cell Therapy market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Animal Stem Cell Therapy Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Dogs Stem Cell Therapy, Horses Stem Cell Therapy)
  • 5.2.2. By Application (Veterinary Hospitals, Research Organizations)
  • 5.2.3. By Region
  • 5.2.4. By Company (2022)
• 5.3. Product Market Map
  • 5.3.1. By Type
  • 5.3.2. By Application
  • 5.3.3. By Region

6. North America Animal Stem Cell Therapy Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type (Dogs Stem Cell Therapy, Horses Stem Cell Therapy)
  • 6.2.2. By Application (Veterinary Hospitals, Research Organizations)
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Animal Stem Cell Therapy Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
  • 6.3.2. Canada Animal Stem Cell Therapy Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
  • 6.3.3. Mexico Animal Stem Cell Therapy Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application

7. Europe Animal Stem Cell Therapy Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type (Dogs Stem Cell Therapy, Horses Stem Cell Therapy)
  • 7.2.2. By Application (Veterinary Hospitals, Research Organizations)
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Animal Stem Cell Therapy Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
  • 7.3.2. United Kingdom Animal Stem Cell Therapy Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
  • 7.3.3. France Animal Stem Cell Therapy Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
  • 7.3.4. Italy Animal Stem Cell Therapy Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Animal Stem Cell Therapy Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Application

8. Asia-Pacific Animal Stem Cell Therapy Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type (Dogs Stem Cell Therapy, Horses Stem Cell Therapy)
  • 8.2.2. By Application (Veterinary Hospitals, Research Organizations)
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Animal Stem Cell Therapy Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
  • 8.3.2. Japan Animal Stem Cell Therapy Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
  • 8.3.3. India Animal Stem Cell Therapy Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
  • 8.3.4. Australia Animal Stem Cell Therapy Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Application
  • 8.3.5. South Korea Animal Stem Cell Therapy Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Application

9. South America Animal Stem Cell Therapy Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type (Dogs Stem Cell Therapy, Horses Stem Cell Therapy)
  • 9.2.2. By Application (Veterinary Hospitals, Research Organizations)
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Animal Stem Cell Therapy Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
  • 9.3.2. Argentina Animal Stem Cell Therapy Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
  • 9.3.3. Colombia Animal Stem Cell Therapy Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application

10. Middle East and Africa Animal Stem Cell Therapy Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type (Dogs Stem Cell Therapy, Horses Stem Cell Therapy)
  • 10.2.2. By Application (Veterinary Hospitals, Research Organizations)
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Animal Stem Cell Therapy Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Application
  • 10.3.2. Saudi Arabia Animal Stem Cell Therapy Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Application
  • 10.3.3. UAE Animal Stem Cell Therapy Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Application
  • 10.3.4. Kuwait Animal Stem Cell Therapy Market Outlook
    • 10.3.4.1. Market Size & Forecast
      • 10.3.4.1.1. By Value
    • 10.3.4.2. Market Share & Forecast
      • 10.3.4.2.1. By Type
      • 10.3.4.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Business Overview
• 14.2. Product Offerings
• 14.3. Recent Developments
• 14.4. Financials (As Reported)
• 14.5. Key Personnel
• 14.6. SWOT Analysis
  • 14.6.1. Ardent Animal Health
  • 14.6.2. Vet Stem Inc
  • 14.6.3. Medrego
  • 14.6.4. Vetbiologics
  • 14.6.5. VETHERAPY
  • 14.6.6. Celavie Biosciences
  • 14.6.7. Magellan Stem Cells
  • 14.6.8. Animal General
  • 14.6.9. Animal Cell Therapies, Inc.
  • 14.6.10. Cell Therapy Sciences Ltd

15. Strategic Recommendations

16. About Us & Disclaimer